A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

NCT04332874 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Myxofibrosarcoma
Undifferentiated Pleomorphic Sarcoma
Alveolar Soft Part Sarcoma

Interventions

PROCEDURE: Isolated Limb Infusion
DRUG: Pembrolizumab
DRUG: infusion of melphalan and dactinomycin

Sponsor

Memorial Sloan Kettering Cancer Center